Skip to main content

Advertisement

Log in

Postural Control in Patients After a Recent Vestibular Neuritis with Hyperhomocysteinemia

  • Original Article
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

To assess the possible role of hyperhomocysteinemia (HyHcy) in delaying recovery after acute vestibular neuritis. In our retrospective study, 90 subjects were evaluated within 7 days from the beginning of an acute vertigo. All subjects had high plasma levels of homocysteine (Hcy). 46 patients were treated with homocysteine lowering therapy and betahistine for 1 month, while 44 subjects received only betahistine. Subjective symptoms were evaluated with the Dizziness Handicap Inventory (DHI) questionnaire, administered 7 days after the beginning of vertigo and again after 1 month. Moreover, postural control performed at 1 month’ control was studied with static stabilometry in a subgroup of 21 non-treated and 20 treated patients. DHI total score decreased significantly more in the subgroup of subjects treated with homocysteine lowering therapy. Moreover, posturographic data were significantly increased in non-treated compared with treated subjects. Our data support the possibility of a role of HyHcy in preventing recovery after a recent vestibular neuritis. A microvascular disorder or the neurotoxic effect of HyHcy have been considered as possible causal factors. Although not conclusive, our data are not inconsistent with the hypothesis of a poorer adaptation in patients with untreated HyHcy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Maron AB, Loscalzo J (2009) The treatment of hyperhomocysteinemia. Annu Rev Med 60:39–54

    Article  PubMed  CAS  Google Scholar 

  2. Gueant-Rodriguez RM, Gueant JL, Debard R, Thirion S, Hong LX, Bronowicki JP et al (2006) Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Am J Clin Nutr 83:701–707

    PubMed  CAS  Google Scholar 

  3. Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, Geffen E et al (2002) The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese and Africans. Am J Hum Genet 70:758–762

    Article  PubMed  CAS  Google Scholar 

  4. Reynolds E (2006) Vitamin B12, folic acid and the nervous system. Lancet Neurol 5:949–960

    Article  PubMed  CAS  Google Scholar 

  5. Harshman MR, Aldoori W (2008) Vitamin B12 and health. Can Fam Physician 54:536–541

    Google Scholar 

  6. Greene NDE, Stainer P, Copp AJ (2009) Genetics of human neural tube defects. Hum Mol Genet 18:R113–R129

    Article  PubMed  CAS  Google Scholar 

  7. Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D’Agostino RB, Wolf PA et al (1999) Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159:1077–1080

    Article  PubMed  CAS  Google Scholar 

  8. Stubbs PJ, Al-Obaidi MK, Conroy MR, Collinson PO, Graham IM, Noble IM (2000) Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndrome. Circulation 102:605–610

    Article  PubMed  CAS  Google Scholar 

  9. Abbate R, Sofi F, Brogi D, Marcucci R (2003) Emerging risk factors for ischemic stroke. Neurol Sci 24:S11–S12

    Article  PubMed  Google Scholar 

  10. Borroni B, Agosti C, Panzali AF, Di Luca M, Padovani A (2002) Homocysteine, vitamin B6 and vascular disease in patients with AD. Neurology 59:1475–1476

    Article  PubMed  CAS  Google Scholar 

  11. Lehmann M, Regland B, Blennow K, Gottfries CG (2003) Vitamin B12–B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinemia and mild cognitive impairment. Dement Geriatr Cogn Disord 16:145–150

    Article  PubMed  CAS  Google Scholar 

  12. Lee EJ, Cho YJ, Yoon YJ (2010) Methylenetetrahydrofolate reductase C677T gene mutation as risk factor for sudden sensorineural hearing loss: association with plasma homocysteine, folate and cholesterol concentration. J Laryngol Otol 124:1268–1273

    Article  PubMed  CAS  Google Scholar 

  13. Fusconi M, Chistolini A, de Virgilio A, Greco A, Massaro F, Turchetta R, Benincasa AT, Tombolini M, de Vincentiis M (2012) Sudden sensorineural hearing loss: a vascular cause? Analysis of prothrombotic risk factors in head and neck. Int J Audiol 51:800–805

    Article  PubMed  Google Scholar 

  14. Fattori B, Nacci A, Ghilardi PL, Bruschini L, Matteucci F, Ursino F (2003) Acute peripheral vertigo: involvement of the hemostatic system. Int Tinnitus J 9:124–129

    PubMed  Google Scholar 

  15. Scaramella JG (2003) Hyperhomocysteinemia and left internal jugular vein thrombosis with Menière’s symptom complex. Ear Nose Throat J 82:859–860

    Google Scholar 

  16. Herdmann SJ (1998) Role of the vestibular adaptation in vestibular rehabilitation. Otolaryngol Head Neck Surg 119:49–54

    Article  Google Scholar 

  17. Jacobson GP, Newman CW (1990) The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg 116:424–427

    Article  PubMed  CAS  Google Scholar 

  18. Whitney SL, Wrisley DM, Brown KE, Furman JM (2004) Is perception of handicap related to functional performance in persons with vestibular dysfunction? Otol Neurotol 25:139–143

    Article  PubMed  Google Scholar 

  19. Kao CL, Chen LK, Chern CM, Hsu LC, Chen CC, Hwang SJ (2010) Rehabilitation outcome in home-based versus supervised exercise programs for chronically dizzy patients. Arch Gerontol Geriatr 51:264–267

    Article  PubMed  Google Scholar 

  20. Beidel DC, Horak FB (2001) Behavior therapy for vestibular rehabilitation. J Anxiety Disord 15:121–130

    Article  PubMed  CAS  Google Scholar 

  21. Dwivedi MK, Tripathi AK, Shukla S, Khan S, Chauhan UK (2011) Homocysteine and cardiovascular disease. Biotechnol Mol Biol Rev 5:101–107

    Google Scholar 

  22. Ho PI, Ortiz D, Rogers E, Shea TB (2002) Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res 70:694–702

    Article  PubMed  CAS  Google Scholar 

  23. Lipton SA, Won-Ki K, Stamler JS (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor. Proc Natl Acad Sci USA 94:5923–5928

    Article  PubMed  CAS  Google Scholar 

  24. Him A, Guneser R, Cengiz N, Ozturk G (2010) Glutamate responsiveness of medial vestibular nucleus neurons in aged rats. Brain Res Bull 81:81–84

    Article  PubMed  CAS  Google Scholar 

  25. Schafer JH, Glass TA, Bolla KI, Mintz M, Jedlicka AE, Schwartz BS (2005) Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc 53:381–388

    Article  PubMed  Google Scholar 

  26. Lalonde R, Barraud H, Ravey J, Gueant JL, Bronowicki JP, Strazielle C (2008) Effects of a B-vitamin deficient diet on exploratory activity, motor coordination, and spatial learning in young adult Balb/c mice. Brain Res 1188:122–131

    Article  PubMed  CAS  Google Scholar 

  27. Streck EL, Bavaresco CS, Netto CA, Wyse AT (2004) Chronic hyperhomocysteinemia provokes a memory deficit in rats in the Morris water maze task. Behav Brain Res 153:377–381

    Article  PubMed  CAS  Google Scholar 

  28. Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM (2003) Folate, vitamin B12, homocysteine, and the MTHFR 677C-T polymorphism in anxiety and depression. Arch Gen Psychiatry 60:618–626

    Article  PubMed  CAS  Google Scholar 

  29. Levine J, Timinsky I, Vishne T, Dwolatzky T, Roitman S, Kaplan Z et al (2008) Elevated serum homocysteine levels in male patients with PTSD. Depress Anxiety 25:E154–E157

    Article  PubMed  Google Scholar 

  30. Darlington CL, Smith PF (2000) Molecular mechanisms of recovery from vestibular damage in mammals: recent advances. Prog Neurobiol 62:313–325

    Article  PubMed  CAS  Google Scholar 

  31. Sans N, Sans A, Raymond J (1997) Regulation of NMDA receptor subunit mRNA expression in the guinea pig vestibular nuclei following UVD. Eur J Neurosci 9:2019–2034

    Article  PubMed  CAS  Google Scholar 

  32. Redfern MS, Talkowski ME, Jennings JR, Furman JM (2004) Cognitive influences in postural control of patients with unilateral vestibular loss. Gait Posture 19:105–114

    Article  PubMed  Google Scholar 

  33. Balaban CD, Jacob RG, Furman JM (2011) Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev Neurother 11:379–394

    Article  PubMed  Google Scholar 

  34. Balaban CD, Thayer JF (2001) Neurological bases for balance-anxiety links. J Anxiety Disord 15:53–79

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Teggi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raponi, G., Teggi, R., Gatti, O. et al. Postural Control in Patients After a Recent Vestibular Neuritis with Hyperhomocysteinemia. Indian J Otolaryngol Head Neck Surg 65, 146–150 (2013). https://doi.org/10.1007/s12070-012-0610-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-012-0610-x

Keywords

Navigation